Literature DB >> 11205088

Clinical findings in a population with back pain. Relation to one-year outcome and long-term sick leave.

T Reigo1, H Tropp, T Timpka.   

Abstract

OBJECTIVE: To investigate whether physical examination findings can be used in predicting recovery from back pain and new episodes of sick leave.
DESIGN: One-year prospective study of a single cohort. SETTINGS: Semi-rural Swedish county. POPULATION: A cross-section of a general population with back pain (207 women, 176 men) between 20 and 59 years of age. MAIN OUTCOME MEASURES: Cumulative incidence of sick leave due to back pain, cumulative incidence of sick leave due to back pain > 30 days, incidence of recovery from back pain.
RESULTS: For recovery from pain, the absence of tenderness in the trapezius muscle (OR 0.33; CI 0.1-0.5) was predictive. New sick leave was predicted by tenderness in the trapezius muscle (OR 2.67; CI 1.5-4.9), and had a tendency to be associated with a flattened lumbar lordosis and a restricted cervical range of motion. For long-term sick leave, the same findings and also observation of scoliosis (OR 3.44; CI 1.1-10.5) were predictive.
CONCLUSION: There are subgroups with back pain predisposed to development of more persistent symptoms and a higher risk for sick-listing.

Entities:  

Mesh:

Year:  2000        PMID: 11205088     DOI: 10.1080/028134300448760

Source DB:  PubMed          Journal:  Scand J Prim Health Care        ISSN: 0281-3432            Impact factor:   2.581


  2 in total

Review 1.  How is recovery from low back pain measured? A systematic review of the literature.

Authors:  Steven J Kamper; Tasha R Stanton; Christopher M Williams; Christopher G Maher; Julia M Hush
Journal:  Eur Spine J       Date:  2010-06-16       Impact factor: 3.134

2.  Analyzing repeated data collected by mobile phones and frequent text messages. An example of low back pain measured weekly for 18 weeks.

Authors:  Iben Axén; Lennart Bodin; Alice Kongsted; Niels Wedderkopp; Irene Jensen; Gunnar Bergström
Journal:  BMC Med Res Methodol       Date:  2012-07-23       Impact factor: 4.615

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.